Endoscopic radiofrequency ablation

PROCEDURE4 trials

Sponsors

Sendai City Medical Center, Assistance Publique - Hôpitaux de Paris, Medical University of Vienna, Centre of Postgraduate Medical Education

Conditions

Barrett EsophagusBarrett OesophagusBiliary Tract NeoplasmsEsophageal AdenocarcinomaLow Grade DysplasiaReflux Diseasecholangiocarcinoma

Phase 2

Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia

CompletedNCT01360541

Assistance Publique - Hôpitaux de ParisBarrett Oesophagus, Low Grade Dysplasia

Start: 2010-12-22End: 2018-12-14Updated: 2025-09-12

Phase 4

Radiofrequency Ablation for Malignant Biliary Obstruction

CompletedNCT01758341

Medical University of ViennaBiliary Tract Neoplasms

Start: 2012-12-31End: 2013-05-31Updated: 2014-01-23

Unknown Phase

Efficacy and safety of the endoscopic radiofrequency ablation for unresectable cholangiocarcinoma: the pilot study

Active, not recruitingJPRN-UMIN000035394

Sendai City Medical Centercholangiocarcinoma

Start: 2017-07-01Target: 10Updated: 2026-06-29

Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus

CompletedNCT05051475

Centre of Postgraduate Medical EducationBarrett Esophagus, Esophageal Adenocarcinoma, Reflux Disease

Start: 2021-12-01End: 2025-05-05Updated: 2025-10-03

Related Papers

Endoscopic radiofrequency ablation or surveillance in patients with Barrett’s oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial

Gut2021-03-0835 citations